Chronic Diarrhea in Children: Case Discussion, Management & Key Points
Model Case Presentation
Patient Demographics
Name: Master Arjun, Age: 2 years, Gender: Male, Informant: Mother (Reliable)
Chief Complaints
- Frequent loose stools (4–6 per day) – 6 weeks
- Abdominal distension – 4 weeks
- Poor weight gain and failure to thrive – 3 months
History Summary
Mother reports 4–6 loose, bulky, pale, foul-smelling stools per day for the last 6 weeks. Stools float in water and leave greasy marks in the pan. No blood or mucus in stools. Abdomen is bloated; child is irritable and lethargic. Diarrhea started approximately 2 weeks after complementary foods containing wheat (roti/porridge) were introduced at 7 months of age but was initially mild and dismissed. Worsening over the last 3 months. Poor weight gain despite adequate dietary intake. No fever. No travel history. No antibiotic use. No family history of similar illness. No vomiting. No jaundice.
Born full-term via NVD, birth weight 3.1 kg. Exclusively breastfed for 6 months. Non-consanguineous marriage.
Examination Summary
| Parameter | Finding | Significance |
|---|---|---|
| Weight | 8.2 kg (expected ~12 kg) | Severe failure to thrive (<−3 SD) |
| Height | 80 cm (expected ~87 cm) | Stunting |
| Temp | 37.0°C | Afebrile |
| Pallor | Present (moderate) | Nutritional/malabsorptive anemia |
| Jaundice / Cyanosis | Absent | — |
| Clubbing | Grade 1 (early) | Chronic malabsorption / IBD |
| Edema | Pedal edema (mild) | Hypoproteinemia from malabsorption |
Abdomen: Distended. Pot belly appearance. Tympanic on percussion. Liver — not enlarged. No spleen. Flank dullness absent. Wasted buttocks (Tanner sign / Baggy pants sign).
Skin/Hair: Hair thin, sparse and depigmented. Angular cheilitis. Aphthous ulcers in the mouth.
Stool characteristics noted by mother: Pale, bulky, greasy, foul-smelling, floating stools → classic steatorrhea.
✅ Complete Diagnosis
Chronic Diarrhea (Malabsorptive type — Steatorrhea) in a 2-year-old male, most likely secondary to Celiac Disease (Gluten-Sensitive Enteropathy), with Severe Failure to Thrive, Hypoproteinemia, and Nutritional Anemia.
💡 Clinical Pearl — Age-Specific Approach
The most common cause of chronic diarrhea differs by age group. In toddlers (1–3 years): Toddler's diarrhea, celiac disease, giardiasis. In school age/adolescents: IBD, IBS, lactose intolerance. In neonates/young infants: Cow's milk protein allergy (CMPA), congenital enteropathies.
📝 History — Exam Q&A
Diarrhea = passage of ≥3 loose/liquid stools per day (WHO definition), or more than the individual's normal frequency.
| Term | Duration |
|---|---|
| Acute diarrhea | < 14 days |
| Persistent diarrhea | 14 days to 4 weeks (some authors use ≥14 days) |
| Chronic diarrhea | > 4 weeks (some texts use >2 weeks as the threshold for children) |
💡 Note for Exam
Different sources define the cutoff as 14 days or 4 weeks. In most pediatric textbooks (Nelson's), chronic diarrhea = >14 days. AAFP/adult gastroenterology use 4 weeks. Know both — in the Indian context, >14 days is widely used.
Classification by Mechanism (Pathophysiological):
| Type | Mechanism | Examples |
|---|---|---|
| Osmotic | Unabsorbed solutes draw water into lumen; stops with fasting; osmotic gap >125 mOsm/kg | Lactose intolerance, carbohydrate malabsorption, celiac disease |
| Secretory | Active ion secretion into lumen; persists with fasting; osmotic gap <50 mOsm/kg | VIPoma, bile acid malabsorption, congenital chloride diarrhea, Giardia |
| Malabsorptive (fatty/steatorrhea) | Impaired absorption of fat/nutrients | Celiac disease, giardiasis, pancreatic exocrine insufficiency (cystic fibrosis), intestinal lymphangiectasia |
| Inflammatory | Mucosal inflammation → bloody ± mucoid stools; elevated fecal calprotectin | IBD (Crohn's, UC), cow's milk protein allergy, infectious colitis, C. difficile |
| Motility-related / Functional | Abnormal gut motility | Toddler's diarrhea (CNSD), IBS, post-infectious IBS, Hirschsprung's overflow |
Classification by Age Group:
| Age Group | Common Causes |
|---|---|
| Neonates / Young infants (<6 months) | Cow's milk protein allergy (CMPA), congenital enteropathies (microvillous inclusion disease, tufting enteropathy), congenital lactase deficiency, congenital chloride diarrhea, immunodeficiency |
| Infants (6–12 months) | Post-infectious enteropathy, secondary lactase deficiency, CMPA, giardiasis, celiac disease (after wheat introduction) |
| Toddlers (1–3 years) | Toddler's diarrhea (CNSD), celiac disease, giardiasis, post-infectious malabsorption, CMPA |
| School age / Adolescents | IBD, IBS, celiac disease, lactose intolerance, Giardia, tuberculosis (in endemic areas) |
Stool Characteristics — the cornerstone of diagnosis:
| Feature | Clue |
|---|---|
| Watery, large volume | Secretory or osmotic etiology; small bowel origin |
| Bloody / mucoid | Inflammatory (IBD, infectious colitis, CMPA) |
| Pale, bulky, foul-smelling, floating, greasy | Steatorrhea → malabsorption (celiac, CF, giardia) |
| Undigested food particles | Toddler's diarrhea, rapid transit |
| Small volume, frequent, urgent | Left colon / rectal disease (IBD-colitis) |
Other key history points:
- Age of onset: Birth → congenital enteropathy; after weaning → celiac; adolescence → IBD/IBS
- Dietary history: Relation to gluten (celiac), cow's milk (CMPA), excessive juice/fructose (toddler's diarrhea), carbohydrates (lactose intolerance)
- Effect of fasting: Stops → osmotic; continues → secretory
- Associated symptoms: Abdominal pain, distension, vomiting, fever, rectal bleeding
- Extraintestinal symptoms: Skin rash (dermatitis herpetiformis in celiac; erythema nodosum in IBD), joint pain (IBD), mouth ulcers (celiac, IBD), perianal disease (Crohn's)
- Growth parameters: Failure to thrive, weight loss
- Travel/exposure: Giardia (contaminated water), infective causes
- Antibiotic use: C. difficile-associated diarrhea
- Family history: IBD, celiac disease (both have genetic predisposition)
- Immunization status and recurrent infections (immunodeficiency)
Toddler's Diarrhea (Chronic Nonspecific Diarrhea of Childhood / CNSD) is the most common cause of chronic diarrhea in children aged 6 months to 3 years. It is a functional disorder with no underlying organic pathology.
Key features:
- 3–6 loose, watery stools per day, often containing undigested food particles ("peas and carrots" appearance)
- Child is well-thriving, active, and healthy — no failure to thrive (this distinguishes it from pathological causes)
- Diarrhea resolves spontaneously by age 3–4 years
- Associated with excessive intake of fruit juices, fructose, sorbitol (osmotic effect)
- May also be due to a low-fat diet (fat slows GI transit)
Management: Reassurance, normalize diet, reduce juice intake, adequate fat in diet. No medications needed.
🚨 Exam Trap
In a child with chronic loose stools but normal growth and no systemic features → think Toddler's Diarrhea first. Do NOT over-investigate.
- Blood in stools (hematochezia or occult blood)
- Failure to thrive or significant weight loss
- Nocturnal diarrhea (wakes child from sleep — never functional)
- Fever (suggests infection or IBD)
- Significant abdominal pain
- Vomiting
- Perianal disease (fistula, skin tags, fissures — Crohn's)
- Onset in the neonatal period (congenital enteropathy)
- Family history of IBD or celiac disease
- Extraintestinal manifestations (joint pain, eye changes, rash)
- Signs of dehydration or electrolyte imbalance
- Recurrent infections / immunodeficiency features
| Dietary Event | Onset of Diarrhea | Diagnosis to Consider |
|---|---|---|
| Birth / from day 1 | Immediate | Congenital secretory diarrhea, congenital chloride diarrhea, microvillous inclusion disease |
| After cow's milk / formula introduction | Days to weeks | Cow's Milk Protein Allergy (CMPA) |
| After introduction of gluten (wheat, rye, barley) | Weeks to months | Celiac disease |
| After breast milk stops | Shortly after | CMPA or congenital lactase deficiency |
| After antibiotic use | During or after course | C. difficile colitis, antibiotic-associated diarrhea |
| After travel or contaminated water exposure | Days to weeks | Giardiasis, amoebiasis |
Celiac Disease (Gluten-Sensitive Enteropathy) is an immune-mediated enteropathy triggered by gluten (a protein in wheat, rye, barley) in genetically susceptible individuals (HLA-DQ2/DQ8), leading to villous atrophy of the small intestine and malabsorption.
Classic presentation (typically 6 months–2 years, after gluten introduction):
- Chronic diarrhea — pale, bulky, foul-smelling, fatty stools (steatorrhea)
- Abdominal distension and bloating
- Failure to thrive, weight loss, muscle wasting
- Wasted buttocks ("Tanner sign" / "Baggy pants" sign)
- Irritability, mood changes
- Anorexia
Atypical/extraintestinal features:
- Iron deficiency anemia (refractory to treatment)
- Short stature
- Delayed puberty
- Dental enamel defects
- Dermatitis herpetiformis (intensely pruritic vesicular rash, typically over buttocks/elbows/knees)
- Peripheral neuropathy, cerebellar ataxia (rare)
- Aphthous ulcers
- Osteoporosis / rickets
At-risk groups: Type 1 diabetes, Down syndrome, Turner syndrome, Williams syndrome, autoimmune thyroid disease, first-degree relatives of celiac patients.
CMPA is the most common food allergy in infants, caused by an abnormal immune response to cow's milk proteins (casein, whey). Affects ~2–3% of infants.
Mechanisms and presentations:
| Mechanism | Presentation | Onset after ingestion |
|---|---|---|
| IgE-mediated (immediate) | Urticaria, vomiting, anaphylaxis | Minutes to 2 hours |
| Non-IgE-mediated / mixed (delayed) | Chronic diarrhea (may be bloody), FTT, food protein-induced enterocolitis syndrome (FPIES) | Hours to days |
Diagnosis: Clinical diagnosis supported by elimination (cow's milk-free diet) → symptom resolution → re-challenge → symptom recurrence. Specific IgE testing / skin prick test (for IgE-mediated only).
Management: Extensive hydrolyzed formula (eHF) or amino acid formula (AAF) for non-breastfed infants. Breastfeeding mothers should eliminate dairy from their diet. Soy formula not recommended in infants <6 months due to cross-reactivity.
Prognosis: Most children (85–90%) outgrow CMPA by age 3–5 years.
Giardia lamblia (now reclassified as G. intestinalis or G. duodenalis) — the most common intestinal parasite causing chronic diarrhea worldwide. It is a protozoan that colonizes the upper small intestine (duodenum/jejunum).
Transmission: Fecal-oral route, contaminated water (resistant to chlorination), person-to-person (daycare settings).
Clinical features:
- Acute watery diarrhea → may become chronic and malabsorptive
- Abdominal cramps, bloating, excessive flatulence (characteristic)
- Foul-smelling, greasy, pale stools (steatorrhea)
- Nausea, anorexia, weight loss
- No blood or mucus in stools (non-invasive organism)
- Failure to thrive in prolonged cases
- Lactose intolerance may develop secondary to mucosal damage
Diagnosis: Stool microscopy for cysts (3 stool samples on alternate days for maximum sensitivity), stool antigen testing (ELISA — more sensitive), PCR.
Treatment: Metronidazole (drug of choice) — 15 mg/kg/day in 3 divided doses × 5–7 days. Alternative: Tinidazole (single dose).
Cystic Fibrosis (CF) is the most common lethal autosomal recessive disorder in Caucasians (relatively rare in Indian population), caused by mutations in the CFTR gene (Cystic Fibrosis Transmembrane Conductance Regulator), encoding a chloride channel.
Mechanism of diarrhea: CFTR mutation → defective chloride secretion → thick, viscous secretions → pancreatic duct obstruction → exocrine pancreatic insufficiency → deficiency of lipase, protease, amylase → maldigestion of fats and proteins → steatorrhea.
GI features:
- Steatorrhea — bulky, oily, foul-smelling stools
- Failure to thrive
- Rectal prolapse (in young children — from straining due to bulky stools)
- Meconium ileus at birth (10–15% of CF cases — pathognomonic)
- Distal intestinal obstruction syndrome (DIOS)
Other features: Recurrent pulmonary infections, bronchiectasis, digital clubbing, male infertility (absence of vas deferens).
Diagnosis: Sweat chloride test (>60 mEq/L diagnostic), CFTR gene mutation analysis, newborn screening (IRT — immunoreactive trypsinogen).
Treatment of pancreatic insufficiency: Pancreatic enzyme replacement therapy (PERT) — pancrelipase with every meal.
IBD comprises Crohn's Disease (CD) and Ulcerative Colitis (UC). Pediatric IBD typically presents in adolescence (10–15 years), though very early-onset IBD (<6 years) can occur.
| Feature | Crohn's Disease | Ulcerative Colitis |
|---|---|---|
| Location | Any part — "skip lesions" — mouth to anus | Colon only (continuous from rectum) |
| Stool | May or may not be bloody; often loose with abdominal pain | Bloody diarrhea with mucus; tenesmus |
| Depth of inflammation | Transmural (all layers) | Mucosal/submucosal only |
| Perianal disease | Common (fistula, skin tags) | Rare |
| Fistula/abscess | Yes | No |
| Strictures | Yes | No (except chronic) |
| Cobblestone mucosa | Yes | No |
| Risk of CRC | Slight increase | Significantly increased (pancolitis >10 years) |
Extraintestinal manifestations (common to both): Arthritis/arthralgia, uveitis/episcleritis, erythema nodosum, pyoderma gangrenosum, primary sclerosing cholangitis (more in UC), growth retardation (especially in CD), delayed puberty.
Diagnostic marker: Elevated fecal calprotectin (>50 µg/g in children), elevated CRP, ESR. Gold standard: Ileocolonoscopy with biopsies.
🩺 Examination — Exam Q&A
- Growth parameters: Weight, height, head circumference — failure to thrive, stunting, wasting
- Nutritional assessment:
- Pallor — iron/folate/B12 deficiency anemia
- Edema — hypoalbuminemia from protein malabsorption
- Clubbing — chronic malabsorption, celiac, IBD
- Parotid enlargement — protein malnutrition
- Hair changes — thin, sparse, hypopigmented hair (kwashiorkor features from protein deficiency)
- Skin — dermatitis herpetiformis (celiac), erythema nodosum (IBD), perianal dermatitis (zinc deficiency)
- Angular cheilitis, glossitis — B vitamins/iron deficiency
- Aphthous mouth ulcers — celiac, IBD
- Bone deformity / rickets — Vitamin D deficiency
- Night blindness / Bitot's spots — Vitamin A deficiency
- Bleeding tendency, bruising — Vitamin K deficiency
- Dehydration signs: Sunken eyes, dry tongue, reduced skin turgor, depressed fontanelle (in infants)
- Pot-belly / abdominal distension: Due to intestinal gas (fermentation of unabsorbed carbohydrates), ascites (hypoproteinemia), dilated intestinal loops
- Tympanic on percussion: Gaseous distension from fermentation
- Wasted buttocks ("Tanner sign" / "Baggy pants" sign): Loss of gluteal fat pad — classic sign of malnutrition from chronic malabsorption
- No hepatosplenomegaly (unless specific cause like storage disorder, tuberculosis)
- Ascites: In severe hypoproteinemia (protein-losing enteropathy, severe malabsorption)
- Perianal disease: Fissures, skin tags, fistula → Crohn's disease
- Visible peristalsis: Intestinal obstruction
The Tanner Sign (Baggy Pants Sign / Wasted Buttocks) refers to the loss of the gluteal fat pad in a child with chronic malnutrition or malabsorption, giving the appearance that their pants/nappy are baggy and hanging. It indicates severe wasting and chronic malabsorption. Classically described in celiac disease and severe protein-energy malnutrition.
| Sign | No Dehydration (<5%) | Some Dehydration (5–10%) | Severe Dehydration (>10%) |
|---|---|---|---|
| General condition | Well, alert | Restless, irritable | Lethargic / unconscious |
| Eyes | Normal | Sunken | Very sunken, dry |
| Tears | Present | Absent | Absent |
| Mouth/tongue | Moist | Dry | Very dry |
| Thirst | Drinks normally | Thirsty, drinks eagerly | Cannot drink / drinks poorly |
| Skin turgor (skin pinch) | Returns immediately (<2 sec) | Goes back slowly (2–3 sec) | Goes back very slowly (>3 sec) |
| Fontanelle (infant) | Normal | Slightly sunken | Very sunken |
| Capillary refill | <2 sec | 2–3 sec | >3 sec |
💡 WHO IMCI Criteria
Two or more signs of "some dehydration" → Plan B (ORS). Signs of "severe dehydration" → Plan C (IV fluids). No signs → Plan A (home management).
- Perianal skin tags, fistulae, fissures, abscesses: Strongly suggest Crohn's disease — perianal involvement occurs in 30–40% of pediatric Crohn's patients
- Perianal dermatitis/rash: Zinc deficiency, frequent acidic stools
- Anal fissures: May also be seen in constipation with overflow diarrhea
- Rectal prolapse: Seen in cystic fibrosis, malnutrition with severe diarrhea, celiac disease
- Scybala on rectal examination: Constipation with overflow/overflow diarrhea (Hirschsprung's disease)
| Sign | Location | Associated Condition |
|---|---|---|
| Dermatitis herpetiformis | Buttocks, elbows, knees — vesicular/blistering rash | Celiac disease (pathognomonic) |
| Erythema nodosum | Pretibial — tender nodules | IBD (Crohn's > UC) |
| Pyoderma gangrenosum | Skin ulcers — usually legs | IBD (UC > Crohn's) |
| Aphthous ulcers | Oral cavity | Celiac disease, Crohn's disease |
| Episcleritis / Uveitis | Eye | IBD (Crohn's > UC) |
| Arthritis / Arthralgia | Large joints | IBD, celiac disease |
| Clubbing | Fingers | Celiac disease, IBD, cystic fibrosis, intestinal lymphangiectasia |
| Barrel chest / wheeze / cough | Chest | Cystic fibrosis |
| Short stature | Growth | Celiac disease, IBD, cystic fibrosis |
| Parotid enlargement | Face | Severe protein malnutrition |
| Eczema / urticaria | Skin | Food allergy (CMPA, IgE-mediated) |
| Lymphadenopathy | Generalized | HIV, TB, lymphoma |
| Feature | Small Bowel Diarrhea | Large Bowel Diarrhea |
|---|---|---|
| Volume | Large volume (often >1 L/day) | Small volume, frequent |
| Blood/mucus | Absent or rare | Often present (blood and mucus) |
| Urgency/tenesmus | Absent | Present (rectal urgency) |
| Fat in stool (steatorrhea) | Often present (malabsorption) | Absent |
| Pain | Periumbilical cramping | Lower abdominal, relieved by defecation |
| Weight loss | Significant (malabsorption) | Variable |
| Examples | Celiac disease, Giardia, CF | IBD-colitis, infectious colitis, CMPA |
🔬 Investigations — Exam Q&A
Step 1 — First-line (Basic) Investigations (All Cases):
- Stool routine microscopy and culture — RBCs, pus cells, cysts, ova, bacteria
- Stool for reducing substances (Clinitest) — carbohydrate malabsorption
- Stool pH — <5.5 suggests carbohydrate malabsorption / lactose intolerance
- Complete blood count (CBC) — anemia (type?), eosinophilia (allergy/parasites), leukocytosis (infection/IBD)
- Serum electrolytes, urea, creatinine — dehydration, electrolyte imbalance
- Serum albumin / total protein — protein malabsorption, protein-losing enteropathy
- Liver function tests
Step 2 — Second-line (Directed by clinical suspicion):
- Stool fat estimation (72-hour or spot Sudan stain) — steatorrhea / malabsorption
- Stool for Giardia antigen (ELISA) — more sensitive than microscopy
- Serology for celiac disease — anti-tissue transglutaminase IgA (anti-tTG IgA) + total serum IgA
- Fecal calprotectin — sensitive marker of intestinal inflammation; >50 µg/g in children suggests IBD
- CRP, ESR — inflammatory markers
- Hydrogen breath test — lactose intolerance, SIBO, carbohydrate malabsorption
- Sweat chloride test — cystic fibrosis
- Thyroid function tests — hyperthyroidism
Step 3 — Advanced / Invasive:
- Upper GI endoscopy with duodenal biopsy — celiac disease (gold standard), Giardia, SIBO, eosinophilic enteropathy
- Colonoscopy with mucosal biopsies — IBD (gold standard), CMPA, infectious colitis
- Small bowel imaging — MRI enterography / CT enterography for Crohn's small bowel disease
- Fecal elastase-1 — exocrine pancreatic insufficiency (<100 µg/g stool is diagnostic)
- Immunological tests (serum immunoglobulins, lymphocyte subsets) — primary immunodeficiency
The Stool Osmotic Gap is the key investigation:
Stool Osmotic Gap = 290 − 2 × (Stool Na⁺ + Stool K⁺)
(290 mOsm/kg = assumed normal plasma/stool osmolality)
| Feature | Osmotic Diarrhea | Secretory Diarrhea |
|---|---|---|
| Osmotic gap | > 125 mOsm/kg (some use >100) | < 50 mOsm/kg |
| Response to fasting | Stops with fasting | Continues with fasting |
| Stool volume | Moderate | Large (often >1 L/day) |
| Stool electrolytes | Low Na + K (unabsorbed solutes dominate) | High Na + K (near-isotonic stool) |
| Stool pH | <5.5 (if carbohydrate cause) | Normal |
| Examples | Lactose intolerance, celiac, osmotic laxatives | VIPoma, congenital chloride diarrhea, bile acid malabsorption, cholera |
💡 Memory Aid
OSmotic = stOPS with fasting. Secretory = continues even in secrecy (fasting).
Serological Tests (Screening):
- Anti-tissue transglutaminase IgA (anti-tTG IgA): First-line test; sensitivity 90–95%, specificity >95%
- Total serum IgA: Must always be checked simultaneously — 2–3% of celiac patients have selective IgA deficiency, giving a false-negative anti-tTG IgA result
- If IgA deficient → check anti-tTG IgG or anti-DGP IgG (deamidated gliadin peptide antibody)
- Anti-endomysial antibody (EMA IgA): High specificity but operator-dependent, used as confirmatory
✅ Gold Standard
Upper GI endoscopy with multiple duodenal biopsies showing villous atrophy (Marsh classification) remains the gold standard for diagnosis of celiac disease.
Marsh Classification of Duodenal Biopsy:
| Marsh Grade | Histology |
|---|---|
| 0 | Normal |
| 1 | Increased intraepithelial lymphocytes (>25 per 100 enterocytes) |
| 2 | Crypt hyperplasia + increased IELs |
| 3a | Partial villous atrophy |
| 3b | Subtotal villous atrophy |
| 3c | Total villous atrophy — classic celiac histology |
ESPGHAN 2020 criteria (no-biopsy pathway): In symptomatic children with anti-tTG IgA ≥10× ULN AND positive EMA AND positive HLA-DQ2/DQ8, biopsy can be avoided and diagnosis made serologically.
Important: Child must be on a gluten-containing diet at the time of testing. Gluten challenge required if gluten was withdrawn before testing.
Fecal calprotectin is a calcium- and zinc-binding protein released from neutrophils during intestinal inflammation. It is measured in stool and serves as a non-invasive marker of intestinal inflammation.
| Level | Interpretation in Children |
|---|---|
| <50 µg/g | Normal (IBD unlikely) |
| 50–200 µg/g | Borderline — repeat or further investigation |
| >200 µg/g | Strongly suggests IBD |
Clinical uses:
- Differentiating IBD from IBS / functional diarrhea (calprotectin normal in functional disorders)
- Monitoring disease activity and treatment response in IBD
- Predicting IBD relapse
- Reduces need for colonoscopy in low-risk patients
Note: Also elevated in infections, CMPA, and other inflammatory conditions — not specific to IBD alone.
Normally, little hydrogen is present in exhaled breath. When unabsorbed carbohydrates reach the colon, colonic bacteria ferment them → produce hydrogen (H₂) and methane → absorbed → excreted in breath.
A rise in exhaled H₂ of >20 ppm above baseline is considered positive.
| Substrate Used | Condition Diagnosed |
|---|---|
| Lactose | Lactose intolerance (lactase deficiency) |
| Fructose | Fructose malabsorption |
| Lactulose | Small intestinal bacterial overgrowth (SIBO) — early peak at <90 min |
| Glucose | SIBO |
Limitation: Antibiotics, proton pump inhibitors, bowel preparation, and high-fiber diet can affect results. False negatives occur in recent antibiotic use.
The 72-hour fecal fat quantification (Van de Kamer method) is the gold standard for diagnosing steatorrhea and malabsorption.
Method: Child is placed on a high-fat diet (35–40% of calories from fat / 2–4 g/kg/day) for 1–2 days before and during the 3-day stool collection period. All stools over 72 hours are collected and total fat content measured.
| Age | Normal Fecal Fat | Steatorrhea (Abnormal) |
|---|---|---|
| <6 months (breastfed) | <1 g/day (can be up to 2g) | >2 g/day |
| <6 months (formula fed) | <1 g/day | >1 g/day |
| >6 months | <2 g/day | >2 g/day |
| Adults | <7 g/day | >7 g/day |
Coefficient of Fat Absorption (CFA): = (Fat intake − fecal fat) / fat intake × 100%. Normal >93% (or >85% in infants).
Simpler alternatives: Spot stool Sudan stain (qualitative), fecal elastase-1 (for pancreatic insufficiency — does not require high-fat diet).
| Stool Finding | Significance |
|---|---|
| Pale, bulky, greasy, foul-smelling, floating | Steatorrhea → malabsorption (celiac, CF, giardiasis, pancreatic insufficiency) |
| Bloody + mucus | Inflammatory diarrhea — IBD, infectious colitis (Shigella, Campylobacter, EIEC), CMPA |
| Watery, large volume, no blood | Secretory diarrhea — VIPoma, cholera, bile acid malabsorption |
| Watery with undigested food particles | Toddler's diarrhea, rapid transit |
| pH <5.5 (acidic stool) | Carbohydrate malabsorption (lactose intolerance), reducing substances positive |
| RBCs + pus cells, no organism | IBD (inflammatory but sterile) |
| Cysts / trophozoites | Giardia (pear-shaped trophozoites, oval cysts), Entamoeba histolytica |
| Eosinophils in stool | CMPA, eosinophilic gastroenteropathy, parasitic infection |
| Positive reducing substances | Carbohydrate malabsorption (lactose, sucrose) — Clinitest |
| Elevated fecal α1-antitrypsin | Protein-losing enteropathy (intestinal lymphangiectasia, IBD, CMPA) |
💊 Management — Exam Q&A
Management is directed at: (A) treating the underlying cause, (B) correcting nutritional deficiencies, (C) maintaining hydration.
1. Rehydration and Electrolyte Correction:
- Oral Rehydration Salts (ORS) — preferred in mild-moderate dehydration (WHO standard ORS / low-osmolarity ORS)
- IV fluids (Ringer's Lactate or Normal Saline) — for severe dehydration or inability to take orally
- Correct hypokalemia (common in prolonged diarrhea)
2. Nutritional Rehabilitation:
- Continue feeding — do NOT starve the child. Continue breastfeeding throughout.
- High-calorie, high-protein diet: 120–150 kcal/kg/day for catch-up growth
- Supplement fat-soluble vitamins (A, D, E, K), zinc, iron, folate as indicated
- Zinc supplementation: 10 mg/day (<6 months) or 20 mg/day (≥6 months) for 10–14 days (WHO recommendation for all children with diarrhea)
3. Treat Underlying Cause (see specific management below)
4. Avoid: Antidiarrheal agents (loperamide, diphenoxylate) — contraindicated in infants and young children with acute/chronic infectious diarrhea.
The only treatment for celiac disease is a strict, lifelong gluten-free diet (GFD).
Gluten must be excluded: Wheat, rye, and barley. Oats are controversial — native oats are often contaminated; most guidelines recommend avoiding until remission.
Allowed: Rice, maize (corn), millets, sorghum, potato, tapioca, soy, quinoa, amaranth.
Monitoring:
- Clinical improvement within 2–4 weeks of GFD
- Anti-tTG IgA normalizes within 6–12 months
- Mucosal recovery on biopsy: 1–2 years
- Annual follow-up with anti-tTG IgA + growth monitoring + dietitian consultation
Nutritional supplementation at diagnosis: Iron, folate, calcium, Vitamin D, B12 as needed depending on deficiency profile.
Consequences of non-compliance: Persistent malabsorption, refractory anemia, osteoporosis, small bowel lymphoma (rare, in adults), dermatitis herpetiformis persisting.
Zinc plays a critical role in intestinal epithelial repair, immune function, and mucosal integrity.
WHO/UNICEF recommendation:
- <6 months: 10 mg/day elemental zinc for 10–14 days
- ≥6 months: 20 mg/day elemental zinc for 10–14 days
Benefits proven in clinical trials:
- Reduces duration and severity of acute diarrhea
- Reduces incidence of diarrhea in the next 2–3 months
- Reduces risk of persistent diarrhea
Zinc deficiency itself causes diarrhea — classic sign is perianal/perioral dermatitis (acrodermatitis enteropathica pattern).
Goals: Induce remission, maintain remission, promote growth, avoid complications.
Crohn's Disease (Induction of remission):
- Exclusive Enteral Nutrition (EEN): First-line in pediatric CD — 6–8 weeks of exclusive formula feeding → induces remission and promotes mucosal healing. Preferred over steroids in children due to growth-promoting effect.
- Corticosteroids (Prednisolone): 1–2 mg/kg/day — used if EEN fails or not tolerated. Not for mucosal healing — only symptom control.
Maintenance (Crohn's):
- Azathioprine / 6-Mercaptopurine (immunomodulators) — first-line maintenance
- Methotrexate — alternative immunomodulator
- Biologics: Infliximab (anti-TNF) — for moderate-severe disease, fistulizing disease, steroid-dependent cases
- Adalimumab (anti-TNF) — alternative biologic
- Ustekinumab (anti-IL-12/23), Vedolizumab (anti-integrin) — newer agents
Ulcerative Colitis:
- Mild-moderate: 5-ASA (mesalazine / sulfasalazine) — oral ± rectal
- Moderate-severe: Corticosteroids → Azathioprine / 6-MP maintenance
- Severe acute colitis (hospitalized): IV methylprednisolone → Infliximab or Cyclosporin (rescue therapy)
- Refractory UC: Colectomy (curative for UC only — not Crohn's)
Probiotics are live microorganisms that, in adequate amounts, confer a health benefit. Evidence-based use in pediatric diarrhea:
| Indication | Evidence | Recommended Strains |
|---|---|---|
| Acute infectious diarrhea | Reduces duration by ~1 day (strongest evidence) | Lactobacillus rhamnosus GG (LGG), Saccharomyces boulardii |
| Antibiotic-associated diarrhea | Moderate evidence | LGG, S. boulardii |
| C. difficile diarrhea (prevention) | Some evidence | S. boulardii, LGG |
| IBD maintenance (UC) | VSL#3 (E. coli Nissle) — moderate evidence | VSL#3, E. coli Nissle 1917 |
| Celiac disease | No proven benefit | — |
| Toddler's diarrhea / IBS | Insufficient evidence | — |
Caution: Avoid in immunocompromised patients (risk of probiotic-associated bacteremia/fungemia).
ORS works via the glucose-sodium co-transporter (SGLT1) in the small intestine — glucose absorption drives sodium (and water) absorption even in secretory diarrhea. This mechanism is intact even in cholera.
| ORS Type | Na⁺ (mEq/L) | Glucose (mmol/L) | Osmolarity |
|---|---|---|---|
| WHO Standard ORS (1975) | 90 | 111 | 311 mOsm/L |
| WHO Low-osmolarity ORS (2002, recommended) | 75 | 75 | 245 mOsm/L |
| WHO Oral Rehydration Salts (UNICEF/WHO sachets) | 75 | 75 | 245 mOsm/L |
Advantages of Low-Osmolarity ORS over Standard ORS:
- Reduced stool output and vomiting
- Reduced IV fluid requirement
- WHO recommends low-osmolarity ORS for all children with diarrhea
- Caution: Slight risk of hyponatremia in cholera — standard ORS preferred in cholera specifically
- Drug of choice: Metronidazole — 15 mg/kg/day in 3 divided doses × 5–7 days (max 750 mg TDS)
- Alternative: Tinidazole — single dose of 50 mg/kg (max 2g) — simpler regimen, higher adherence
- Alternative: Albendazole 400 mg/day × 5 days
- Nitazoxanide — for metronidazole-resistant or recurrent cases
Household contacts should also be investigated and treated.
Secondary lactase deficiency may persist 3–4 weeks after treatment — temporary lactose restriction may be needed.
Post-infectious malabsorption syndrome (Post-enteritis syndrome) occurs when an acute intestinal infection causes persistent mucosal damage → villous atrophy → secondary disaccharidase deficiency (especially lactase) → osmotic diarrhea continues after the infection is resolved.
Common after: Rotavirus gastroenteritis, Giardia, Cryptosporidium, EIEC, severe malnutrition with infections.
Management:
- Temporary lactose-free diet — use lactose-free formula or soy-based formula for 4–8 weeks
- Nutritional rehabilitation — high-calorie diet
- Do not re-challenge with regular milk for 4–6 weeks
- Prognosis generally good — mucosal recovery occurs with nutritional support
🔭 Recent Advances — Exam Q&A
The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) 2020 guidelines allow diagnosis of celiac disease without duodenal biopsy in symptomatic children meeting all the following criteria:
- Anti-tTG IgA ≥10× the upper limit of normal (ULN)
- AND Positive anti-EMA IgA (in a separate blood sample)
- AND Positive HLA-DQ2 and/or HLA-DQ8
- Patient is on a gluten-containing diet at time of testing
This "no-biopsy pathway" avoids invasive endoscopy in select children. Biopsy still recommended in asymptomatic individuals, IgA-deficient patients, and equivocal cases.
The gut microbiome (trillions of bacteria, viruses, fungi in the intestine) plays a critical role in mucosal immunity, epithelial integrity, and nutrient absorption. Dysbiosis — an imbalance in microbial composition — has been implicated in several conditions:
- IBD: Reduced microbial diversity, decreased Faecalibacterium prausnitzii (anti-inflammatory commensal), increased Proteobacteria
- IBS: Dysbiosis may drive visceral hypersensitivity and altered motility
- C. difficile diarrhea: Disruption of normal flora by antibiotics allows C. difficile overgrowth
- Small Intestinal Bacterial Overgrowth (SIBO): >10⁵ CFU/mL in proximal jejunum → deconjugation of bile acids → fat malabsorption
Fecal Microbiota Transplantation (FMT): Proven highly effective for recurrent C. difficile colitis. Experimental for IBD and IBS. Not yet standard for pediatric use beyond CDI.
| Drug | Class / Target | Indication | Approved Age |
|---|---|---|---|
| Infliximab (Remicade) | Anti-TNF-α (IV infusion) | Moderate-severe Crohn's and UC; fistulizing CD | ≥6 years |
| Adalimumab (Humira) | Anti-TNF-α (SC injection) | Moderate-severe CD (UC in adults) | ≥6 years |
| Vedolizumab (Entyvio) | Anti-integrin (α4β7) — gut selective | Moderate-severe CD and UC | ≥6 years (off-label; trials ongoing) |
| Ustekinumab (Stelara) | Anti-IL-12/23 (anti-p40) | Moderate-severe CD; UC | Adults; ≥6 years (off-label, trials) |
| Risankizumab | Anti-IL-23 (anti-p19) | Moderate-severe CD (adults, newer) | Adults |
Prior to biologics: Screen for tuberculosis (PPD/IGRA, CXR), hepatitis B, VZV immunity. Live vaccines are contraindicated during biologic therapy.
CODEs are rare, monogenic disorders causing severe, intractable diarrhea presenting in neonates and early infancy. They are often life-threatening without specialized treatment.
| Category | Disorder | Gene | Key Feature |
|---|---|---|---|
| Epithelial transport defects | Congenital Chloride Diarrhea | SLC26A3 | High stool Cl⁻, alkalosis, distended abdomen from birth |
| Epithelial transport defects | Glucose-Galactose Malabsorption | SLC5A1 | Severe osmotic diarrhea; resolves on fructose-only diet |
| Epithelial trafficking defects | Microvillous Inclusion Disease (MVID) | MYO5B, STX3 | Severe watery diarrhea from birth; EM shows microvillus inclusions; requires PN/intestinal transplant |
| Epithelial structural defects | Tufting Enteropathy (Intestinal Epithelial Dysplasia) | EPCAM | Biopsy shows "tufts" of enterocytes; severe malabsorption from infancy |
| Immune dysregulation | Autoimmune Enteropathy (IPEX syndrome) | FOXP3 | Neonatal onset, severe malabsorption + multi-organ autoimmunity; anti-enterocyte antibodies |
Management: Total Parenteral Nutrition (TPN) as cornerstone. Intestinal transplantation for intractable cases (MVID, tufting enteropathy). Gene-specific treatment in some.
Environmental Enteric Dysfunction (EED) (also called Environmental Enteropathy) is a subclinical, acquired inflammatory condition of the small intestine found in children living in low- and middle-income countries (LMICs) in conditions of poor sanitation, hygiene, and high pathogen burden.
Key features:
- Chronic repeated exposure to enteric pathogens → low-grade persistent intestinal inflammation → partial villous atrophy, crypt hyperplasia, increased intestinal permeability
- May not cause overt diarrhea
- Results in growth stunting, linear growth faltering, and impaired vaccine responses
- Contributes to up to 40% of stunting in LMICs
Biomarkers: Elevated fecal calprotectin, fecal neopterin, urinary lactulose:mannitol ratio (gut permeability test), plasma lipopolysaccharide-binding protein (LBP).
Interventions under study: WASH (Water, Sanitation, Hygiene) programs, nutritional interventions, and targeted antibiotics/anthelmintics. No proven single cure yet.
⚡ Key Points — Quick Revision
One-Liners for Exam
- Chronic diarrhea definition: Loose stools >14 days (Nelson's pediatric); OR >4 weeks (AAFP/adults)
- Most common cause overall (children): Post-infectious / toddler's diarrhea in functional; Celiac disease in organic malabsorptive
- Most common cause in Indian children (organized study): Celiac disease (26%), followed by parasites (9%), TB (5%)
- Toddler's diarrhea: Functional, well-thriving child, undigested food in stools, age 6 months–3 years — NO investigation needed
- Steatorrhea (pale, bulky, greasy, foul-smelling, floating stool): Malabsorption — celiac, CF, Giardia, pancreatic insufficiency
- Osmotic diarrhea: Stops with fasting; osmotic gap >125 mOsm/kg
- Secretory diarrhea: Continues with fasting; osmotic gap <50 mOsm/kg; large volume
- Nocturnal diarrhea: NEVER functional — always organic (IBD, secretory tumor)
- Celiac screening: Anti-tTG IgA + Total IgA
- Celiac gold standard: Duodenal biopsy — Marsh 3 (villous atrophy)
- ESPGHAN 2020 no-biopsy: Anti-tTG ≥10× ULN + EMA positive + HLA-DQ2/DQ8 — biopsy can be skipped
- Celiac treatment: Lifelong strict gluten-free diet
- Dermatitis herpetiformis: Pathognomonic skin manifestation of celiac disease
- Giardia diagnosis: Stool antigen (ELISA) — most sensitive; stool microscopy (3 samples on alternate days)
- Giardia treatment: Metronidazole 15 mg/kg/day × 5–7 days (or single-dose Tinidazole)
- Fecal calprotectin >200 µg/g: Strongly suggests IBD
- IBD hallmark difference: Crohn = skip lesions, transmural, any GI tract, perianal disease; UC = continuous from rectum, mucosal only, colon only
- EEN: First-line for pediatric Crohn's induction — superior to steroids for mucosal healing
- UC surgery: Colectomy is curative; Crohn's = not curable by surgery
- CF → diarrhea mechanism: Pancreatic exocrine insufficiency → maldigestion → steatorrhea
- CF diagnosis: Sweat chloride >60 mEq/L + CFTR gene mutation
- CF treatment of GI: Pancreatic enzyme replacement (pancrelipase) with every meal
- CMPA diagnosis: Elimination and re-challenge; treatment = extensive hydrolyzed formula (eHF)
- Zinc supplementation: 10 mg/day (<6 months) or 20 mg/day (≥6 months) × 10–14 days for all children with diarrhea
- ORS mechanism: Glucose-sodium cotransport (SGLT1) — intact even in secretory diarrhea
- Low-osmolarity ORS (WHO 2002): Na 75 mEq/L, Glucose 75 mmol/L, Osmolarity 245 mOsm/L
- Antidiarrheals (loperamide): Contraindicated in infants and young children
- Baggy pants sign (Tanner sign): Wasted gluteal fat pad — chronic malabsorption/malnutrition
- MVID: Neonatal onset, severe watery diarrhea, microvillus inclusions on EM — requires intestinal transplant
- IPEX syndrome: FOXP3 mutation → regulatory T cell defect → autoimmune enteropathy + multi-organ autoimmunity
- EED: Subclinical small bowel inflammation in LMICs → stunting and impaired vaccine response
🚨 Exam Traps
- Always check total serum IgA with anti-tTG IgA — IgA deficiency gives false-negative celiac serology
- Gluten challenge before testing celiac serology if child was already on GFD
- Toddler's diarrhea → child is well and thriving — if FTT is present, do NOT diagnose toddler's diarrhea without investigating
- Osmotic gap formula: 290 − 2(stool Na + stool K) — not serum electrolytes
- Fecal calprotectin is elevated in IBD but also in infections — not IBD-specific alone
